🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study Objective: To assess the value of Rivaroxaban for the prevention of v...
Status
Completed
Location
Thrombosis Center & Knee Arthroscopy and Sports Medicine Center, Humanitas Clinical Insitute
Start Date
2012-05
Trial ID
NCT01629381
Treatments Being Tested
This study will evaluate if extended therapy with oral rivaroxaban can prev...
Status
Completed
Location
Multiple Locations
Start Date
2007-12
Trial ID
NCT00571649
Treatments Being Tested
The clinical significance of pulmonary embolism (PE) limited to the subsegm...
Status
Recruiting
Location
Cliniques Universitaires Saint-Luc
Start Date
2020-05-15
Trial ID
NCT04263038
Treatments Being Tested
Rivaroxaban or placebo for extended antithrombotic prophylaxis after laparo...
Status
Completed
Location
Ospedale Santa Maria delle Grazie
Start Date
2017-05-03
Trial ID
NCT03055026
Treatments Being Tested
The purpose of this study is to determine whether rivaroxaban in addition t...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00809965
Treatments Being Tested
Surgical hip replacement (total hip arthroplasty, THA) is associated with a...
Status
Recruiting
Location
Kepler University Medical Center, Orthopedics and Traumatology
Start Date
2024-11-26
Trial ID
NCT06611319
Treatments Being Tested
The study will enroll 200 women newly diagnosed with peripartum cardiomyopa...
Status
Recruiting
Location
University of Alabama Birmingham
Start Date
2022-07-27
Trial ID
NCT05180773
Glioma is a common brain tumor with a high risk of venous thromboembolism d...
Status
Unknown
Location
Beijing Tiantan Hospital
Start Date
2023-11-01
Trial ID
NCT06196918
Treatments Being Tested
The purpose of this study is to evaluate whether rivaroxaban reduces the ri...
Status
Terminated
Location
University of Arizona
Start Date
2020-08-13
Trial ID
NCT04508023
Treatments Being Tested
The primary objectives of this study are: * To determine whether rivaroxab...
Status
Completed
Location
Multiple Locations
Start Date
2013-02-28
Trial ID
NCT01776424